For Clinicians

An objective signal for radiation dermatitis severity — roughly 72 hours before visible symptoms.

How ChromaShield helps

The patch uses a three-layer design: a medical-grade polyurethane film for durability, a thermochromic temperature-monitoring layer that changes color in response to skin changes, and a gentle, reusable medical-grade adhesive layer.

Status

Bench testing underway

Patent

2 patent-pending prototypes

Clinical study

Projected in 2026

Regulatory

FDA 510(k), 21 CFR 880.2900

Reimbursement

ChromaShield is designed to fit existing billing workflows — similar to how dressings and skin positioning markers are grouped into radiation treatment reimbursement today, purchased in bulk at low per-unit cost.

Interested in a conversation or collaboration?

We're actively speaking with clinicians as we shape ChromaShield's development.